Vertex Pharmaceuticals Heading $600? A Stock Outlook
Investors keep asking if Vertex Pharmaceuticals is headed to $600. This article breaks down the core business, pipeli...
Understanding the value of points versus cash back helps you make smart financial choices. Compare both to see which is more beneficial.
28,655 articlesInvestors keep asking if Vertex Pharmaceuticals is headed to $600. This article breaks down the core business, pipeli...
Mastercard unveiled a sweeping Crypto Partner Program that brings together Ripple, Binance, PayPal and dozens more to...
Two concrete signals could shape the S&P 500 this week in the wake of Signet Jewelers' earnings. This guide explains ...
Trump’s move to bring Elon Musk into a China diplomacy frame marks a dramatic shift for investors. The pairing could ...
Nvidia CEO Jensen Huang describes a 1,000% surge in AI compute for agentic AI, triggering a broad rethink of data cen...
Zillow has filed for a federal injunction to stop MRED from cutting off IDX and VOW data feeds, while MRED presses fo...
Israel expanded its Lebanon assault, widening ground incursions as Hezbollah escalates strikes. The move rattles mark...
A six-year analysis ties CEO ego cues to push for in-person work, highlighting how office-first power dynamics influe...
Shopify delivered strong quarterly results, but the stock traded lower as guidance softened. This article explains wh...
When a major investor dumped million from a high-yield closed-end fund, it sent a clear message about risk, liquidity...
With economic uncertainty builds rising and consumer costs stubborn, Dave Ramsey points to three core moves to weathe...
BitMine Immersion Technologies’ largest ETH purchase of the year lifts holdings to about 5.39 million ETH, reinforcin...